Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Polycythemia"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 21-40 z 11857
Tytuł:
Labor market affiliation of patients with myeloproliferative neoplasms: a population-based matched cohort study.
Autorzy:
Svingel LS; Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University Hospital and Aarhus University, Denmark.
Christensen SF; Department of Hematology, Zealand University Hospital, Denmark.
Kjærsgaard A; Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University Hospital and Aarhus University, Denmark.
Stenling A; Novartis Sverige AB, Sweden.
Paulsson B; Novartis Sverige AB, Sweden.
Andersen CL; Department of Hematology, Copenhagen University Hospital, Rigshospitalet, Denmark.
Christiansen CF; Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University Hospital and Aarhus University, Denmark.
Stentoft J; Department of Hematology, Aarhus University Hospital, Denmark.
Starklint J; Department of Medicine, Goedstrup Hospital, Denmark.
Severinsen MT; Department of Hematology, Aalborg University Hospital, Denmark.
Borg Clausen M; Department of Hematology, Copenhagen University Hospital, Rigshospitalet, Denmark.
Hagemann Hilsøe M; Department of Hematology, Hospital of South West Jutland, Denmark.
Hasselbalch HC; Department of Hematology, Zealand University Hospital, Denmark.
Frederiksen H; Department of Hematology, Odense University Hospital, Denmark.
Bak M; Department of Hematology, Zealand University Hospital, Denmark.
Mikkelsen EM; Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University Hospital and Aarhus University, Denmark.
Pokaż więcej
Źródło:
Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2023 Oct; Vol. 62 (10), pp. 1286-1294. Date of Electronic Publication: 2023 Sep 01.
Typ publikacji:
Journal Article
MeSH Terms:
Polycythemia Vera*/epidemiology
Primary Myelofibrosis*/epidemiology
Thrombocythemia, Essential*
Myeloproliferative Disorders*
Humans ; Cohort Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Tyrosine phosphorylation of band 3 impairs the storage quality of suspended red blood cells in the Tibetan high-altitude polycythemia population.
Autorzy:
Wu X; Department of Critical Care Medicine, Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region, Chengdu, 610041, People's Republic of China.
Liu Z; Department of Blood Transfusion, People's Hospital of Tibet Autonomous Region, Lhasa, 851400, Tibet, People's Republic of China.
Hao D; Department of Biobank, Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region, Ximianqiao Rd #20, Wuhou District, Chengdu, 610041, People's Republic of China.
Zhao Q; Department of Biobank, Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region, Ximianqiao Rd #20, Wuhou District, Chengdu, 610041, People's Republic of China.
Li W; Center of Biomedical Engineering, Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Huacai Rd #26, Chenghua District, Chengdu, 610052, People's Republic of China.
Xie M; Laboratory of Mitochondria and Metabolism, Department of Anesthesiology, National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, 610041, China.
Feng X; Department of Critical Care Medicine, Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region, Chengdu, 610041, People's Republic of China.
Liao X; Department of Critical Care Medicine, Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region, Chengdu, 610041, People's Republic of China.
Chen S; Department of Biobank, Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region, Ximianqiao Rd #20, Wuhou District, Chengdu, 610041, People's Republic of China.
Wang S; Department of Biobank, Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region, Ximianqiao Rd #20, Wuhou District, Chengdu, 610041, People's Republic of China.
Zhou C; Department of Biobank, Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region, Ximianqiao Rd #20, Wuhou District, Chengdu, 610041, People's Republic of China.
Long W; Department of Endocrinology and Metabolism, Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region, Ximianqiao Rd #20, Wuhou District, Chengdu, 610041, People's Republic of China.
Zhong Y; Department of Endocrinology and Metabolism, Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region, Ximianqiao Rd #20, Wuhou District, Chengdu, 610041, People's Republic of China.
Li S; Center of Biomedical Engineering, Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Huacai Rd #26, Chenghua District, Chengdu, 610052, People's Republic of China.
Cao Y; Center of Biomedical Engineering, Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Huacai Rd #26, Chenghua District, Chengdu, 610052, People's Republic of China.
Wang H; Center of Biomedical Engineering, Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Huacai Rd #26, Chenghua District, Chengdu, 610052, People's Republic of China.
Wang A; Department of Blood Transfusion, People's Hospital of Tibet Autonomous Region, Lhasa, 851400, Tibet, People's Republic of China.
Xu Y; Department of Blood Transfusion, People's Hospital of Tibet Autonomous Region, Lhasa, 851400, Tibet, People's Republic of China.
Huang M; Department of Blood Transfusion, Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region, Chengdu, 610041, People's Republic of China.
Liu J; Center of Biomedical Engineering, Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Huacai Rd #26, Chenghua District, Chengdu, 610052, People's Republic of China. .
Zhong R; Center of Biomedical Engineering, Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Huacai Rd #26, Chenghua District, Chengdu, 610052, People's Republic of China. .
Wu Y; Department of Endocrinology and Metabolism, Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region, Ximianqiao Rd #20, Wuhou District, Chengdu, 610041, People's Republic of China. wu_.
He Z; Department of Biobank, Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region, Ximianqiao Rd #20, Wuhou District, Chengdu, 610041, People's Republic of China. .
Pokaż więcej
Źródło:
Journal of translational medicine [J Transl Med] 2023 Sep 28; Vol. 21 (1), pp. 676. Date of Electronic Publication: 2023 Sep 28.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Polycythemia*/complications
Altitude Sickness*
Humans ; Tibet ; Altitude ; Phosphorylation ; Erythrocytes ; Hemoglobins ; Tyrosine
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Clinical Impact of JAK2V617F Allele Burden in Philadelphia-Negative Myeloproliferative Neoplasms
Autorzy:
Yönal-Hindilerden İ; İstanbul University İstanbul Medical Faculty, Department of Internal Medicine, Division of Hematology, İstanbul, Türkiye
Şahin E; İstanbul University İstanbul Medical Faculty, Department of Internal Medicine, Division of Hematology, İstanbul, Türkiye
Hindilerden F; University of Health Sciences Türkiye Bakırköy Dr. Sadi Konuk Training and Research Hospital, Clinic of Hematology, İstanbul, Türkiye
Dağlar-Aday A; İstanbul University İstanbul Medical Faculty, Department of Internal Medicine, Division of Medical Genetics, İstanbul, Türkiye
Nalçacı M; İstanbul University İstanbul Medical Faculty, Department of Internal Medicine, Division of Hematology, İstanbul, Türkiye
Pokaż więcej
Źródło:
Turkish journal of haematology : official journal of Turkish Society of Haematology [Turk J Haematol] 2023 Aug 31; Vol. 40 (3), pp. 174-182. Date of Electronic Publication: 2023 Aug 16.
Typ publikacji:
Journal Article
MeSH Terms:
Primary Myelofibrosis*/genetics
Myeloproliferative Disorders*/diagnosis
Myeloproliferative Disorders*/genetics
Polycythemia Vera*/genetics
Thrombocythemia, Essential*/diagnosis
Thrombocythemia, Essential*/genetics
Humans ; Alleles ; Splenomegaly ; Janus Kinase 2/genetics ; Mutation
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Changes in expression levels of erythrocyte and immune-related genes are associated with high altitude polycythemia.
Autorzy:
Feng S; Key Laboratory for Molecular Genetic Mechanisms and Intervention Research on High Altitude Disease of Tibet Autonomous region, Key Laboratory of High Altitude Environment and Genes Related to Diseases of Tibet Autonomous Region, School of Medicine, Xizang Minzu University, Xianyang, Shaanxi, 712082, China.
Wei G; Ministry of Education (MOE) Key Laboratory of Contemporary Anthropology, Collaborative Innovation Center of Genetics and Development, Human Phenome Institute, School of Life Sciences, Fudan University, Shanghai, 200438, China.
Yang X; The Second People's Hospital of Tibet Autonomous Region, Lhasa, Tibet, 850000, China.
Zhang Z; Key Laboratory for Molecular Genetic Mechanisms and Intervention Research on High Altitude Disease of Tibet Autonomous region, Key Laboratory of High Altitude Environment and Genes Related to Diseases of Tibet Autonomous Region, School of Medicine, Xizang Minzu University, Xianyang, Shaanxi, 712082, China.
Qu J; The Second People's Hospital of Tibet Autonomous Region, Lhasa, Tibet, 850000, China.
Wang D; The Second People's Hospital of Tibet Autonomous Region, Lhasa, Tibet, 850000, China.
Zhou T; Key Laboratory for Molecular Genetic Mechanisms and Intervention Research on High Altitude Disease of Tibet Autonomous region, Key Laboratory of High Altitude Environment and Genes Related to Diseases of Tibet Autonomous Region, School of Medicine, Xizang Minzu University, Xianyang, Shaanxi, 712082, China.
Ni T; Ministry of Education (MOE) Key Laboratory of Contemporary Anthropology, Collaborative Innovation Center of Genetics and Development, Human Phenome Institute, School of Life Sciences, Fudan University, Shanghai, 200438, China. .
Liu L; Key Laboratory for Molecular Genetic Mechanisms and Intervention Research on High Altitude Disease of Tibet Autonomous region, Key Laboratory of High Altitude Environment and Genes Related to Diseases of Tibet Autonomous Region, School of Medicine, Xizang Minzu University, Xianyang, Shaanxi, 712082, China. .
Kang L; Key Laboratory for Molecular Genetic Mechanisms and Intervention Research on High Altitude Disease of Tibet Autonomous region, Key Laboratory of High Altitude Environment and Genes Related to Diseases of Tibet Autonomous Region, School of Medicine, Xizang Minzu University, Xianyang, Shaanxi, 712082, China. longli_.
Pokaż więcej
Źródło:
BMC medical genomics [BMC Med Genomics] 2023 Jul 28; Vol. 16 (1), pp. 174. Date of Electronic Publication: 2023 Jul 28.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Altitude Sickness*/genetics
Altitude Sickness*/complications
Polycythemia*/genetics
Polycythemia*/complications
Humans ; Altitude ; Erythrocytes/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Secondary polycythaemia from chronic hypoxia is a risk for cerebral thrombosis: a case report.
Autorzy:
Zhou M; Department of Neurology, Ningbo No. 2 Hospital, 41 Xi'bei Street, Ningbo, Zhejiang, China.
Liu X; Department of Neurology, Ningbo No. 2 Hospital, 41 Xi'bei Street, Ningbo, Zhejiang, China.
Li L; Department of Neurology, Ningbo No. 2 Hospital, 41 Xi'bei Street, Ningbo, Zhejiang, China. .
Pokaż więcej
Źródło:
BMC neurology [BMC Neurol] 2023 Jun 09; Vol. 23 (1), pp. 225. Date of Electronic Publication: 2023 Jun 09.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Polycythemia*/complications
Thrombosis*/etiology
Intracranial Thrombosis*/complications
Male ; Humans ; Middle Aged ; Hypoxia/complications ; Oxygen
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A Young Patient with Undiagnosed Polycythemia-Paraganglioma Syndrome: A Case Report.
Autorzy:
Alaklabi AM; College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
Arabi TZ; College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
Bin Saeedan MN; Department of Radiology, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.
Alotaibi GS; Department of Medicine, Hematology/Oncology Division (Oncology Center), College of Medicine, King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia.
Pokaż więcej
Źródło:
The American journal of case reports [Am J Case Rep] 2023 May 10; Vol. 24, pp. e938676. Date of Electronic Publication: 2023 May 10.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Polycythemia*/diagnosis
Polycythemia*/etiology
Paraganglioma*/diagnosis
Pheochromocytoma*
Adrenal Gland Neoplasms*
Female ; Humans ; Adolescent ; Positron Emission Tomography Computed Tomography
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Determinants of neonatal jaundice among neonates admitted to neonatal intensive care unit in public hospitals of Sidama Region, Sidama, Ethiopia, 2022: an unmatched case-control study.
Autorzy:
Sisay BD; Department of Midwifery, Hawassa University, Hawassa, Sidama, Ethiopia.
Abebe RF; Department of Midwifery, Hawassa University, Hawassa, Sidama, Ethiopia.
Kassie AA; Department of Midwifery, Hawassa University, Hawassa, Sidama, Ethiopia.
Wondimu MG; Department of Midwifery, Jimma University, Jimma, Oromia, Ethiopia.
Kassie GA; Department of Epidemiology and Biostatistics, School of Public Health, Wolayita Sodo University, Sodo, Ethiopia.
Pokaż więcej
Źródło:
The Pan African medical journal [Pan Afr Med J] 2023 Jul 06; Vol. 45, pp. 117. Date of Electronic Publication: 2023 Jul 06 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Jaundice, Neonatal*/epidemiology
Polycythemia*
Jaundice*
Infant, Newborn ; Female ; Humans ; Case-Control Studies ; Intensive Care Units, Neonatal ; Ethiopia/epidemiology ; Hospitals, Public
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Higher estimated plasma volume status is associated with increased thrombotic risk and impaired survival in patients with primary myelofibrosis.
Autorzy:
Lucijanic M; Hematology Department, University Hospital Dubrava, Zagreb, Croatia.; University of Zagreb School of Medicine, Zagreb, Croatia.
Krecak I; Department of Internal Medicine, General Hospital Sibenik, Sibenik, Croatia.; University of Rijeka School of Medicine, Rijeka, Croatia.
Soric E; Hematology Department, University Hospital Dubrava, Zagreb, Croatia.
Sabljic A; Hematology Department, University Hospital Dubrava, Zagreb, Croatia.
Galusic D; Department of Hematology, University Hospital Center Split, Split, Croatia.; University of Split School of Medicine, Split, Croatia.
Holik H; Department of Internal Medicine, 'Dr. Josip Bencevic' General Hospital, Slavonski Brod, Croatia.; University of Osijek Faculty of Medicine, Osijek, Croatia.
Perisa V; University of Osijek Faculty of Medicine, Osijek, Croatia.; Department of Hematology, Osijek University Hospital, Osijek, Croatia.
Peric MM; Department of Internal Medicine, General Hospital Zadar, Zadar, Croatia.
Zekanovic I; Department of Internal Medicine, General Hospital Zadar, Zadar, Croatia.
Kusec R; Hematology Department, University Hospital Dubrava, Zagreb, Croatia.; University of Zagreb School of Medicine, Zagreb, Croatia.
Pokaż więcej
Źródło:
Biochemia medica [Biochem Med (Zagreb)] 2023 Jun 15; Vol. 33 (2), pp. 020901. Date of Electronic Publication: 2023 Apr 15.
Typ publikacji:
Journal Article
MeSH Terms:
Primary Myelofibrosis*/genetics
Thrombosis*
Polycythemia Vera*
Humans ; Retrospective Studies ; Plasma Volume ; Prognosis ; Inflammation
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Deep Medullary Vein Thrombosis in a Neonate with Asymptomatic Polycythemia.
Autorzy:
Naik S; Department of Radiodiagnosis, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.
Nayak MK; Department of Radiodiagnosis, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.
Sahoo T; Department of Neonatology, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.
Bhoi SK; Department of Neurology, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.
Pokaż więcej
Źródło:
Neurology India [Neurol India] 2023 May-Jun; Vol. 71 (3), pp. 613-614.
Typ publikacji:
Journal Article
MeSH Terms:
Polycythemia*/complications
Thrombosis*
Infant, Newborn ; Humans
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Compound in-cis JAK2 mutant polycythemia vera manifesting as first-onset transient ischemic attack with erythrocytosis and an attenuated JAK2 V617F mutant signal on a quantitative DD-PCR assay.
Autorzy:
Ng IKS; Department of Medicine, National University Hospital, Singapore, Singapore.
Lee PL; Molecular Diagnosis Center, Department of Laboratory Medicine, National University Hospital, Singapore, Singapore.
Ng LJ; Molecular Diagnosis Center, Department of Laboratory Medicine, National University Hospital, Singapore, Singapore.
Chua RP; Molecular Diagnosis Center, Department of Laboratory Medicine, National University Hospital, Singapore, Singapore.
Ng YA; Molecular Diagnosis Center, Department of Laboratory Medicine, National University Hospital, Singapore, Singapore.
Lee CK; Molecular Diagnosis Center, Department of Laboratory Medicine, National University Hospital, Singapore, Singapore.
Tan JG; Department of Laboratory Medicine, Khoo Teck Puat Hospital, Singapore, Singapore.
Chan THM; Molecular Diagnosis Center, Department of Laboratory Medicine, National University Hospital, Singapore, Singapore.
Yan B; Molecular Diagnosis Center, Department of Laboratory Medicine, National University Hospital, Singapore, Singapore.
Prasad V; Department of Laboratory Medicine, Khoo Teck Puat Hospital, Singapore, Singapore.
Pokaż więcej
Źródło:
International journal of laboratory hematology [Int J Lab Hematol] 2023 Apr; Vol. 45 (2), pp. e28-e31. Date of Electronic Publication: 2022 Oct 07.
Typ publikacji:
Letter
MeSH Terms:
Ischemic Attack, Transient*/etiology
Ischemic Attack, Transient*/genetics
Janus Kinase 2*/genetics
Polycythemia*/diagnosis
Polycythemia*/etiology
Polycythemia*/genetics
Polycythemia Vera*/complications
Polycythemia Vera*/diagnosis
Polycythemia Vera*/genetics
Humans ; Mutation ; Polymerase Chain Reaction
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Rare Case of Concomitant Polycythemia Vera and Chronic Lymphocytic Leukemia in a Young Male Patient.
Autorzy:
Li T; Beijing Lu Daopei Hospital, Department of Laboratory Medicine, Beijing, China.
Zhang Y; The District People's Hospital of Zhangqiu, Department of Clinical Laboratory, Shandong Province, China.
Pokaż więcej
Źródło:
Turkish journal of haematology : official journal of Turkish Society of Haematology [Turk J Haematol] 2023 Feb 28; Vol. 40 (1), pp. 77-79.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Leukemia, Lymphocytic, Chronic, B-Cell*/complications
Leukemia, Lymphocytic, Chronic, B-Cell*/diagnosis
Polycythemia Vera*/complications
Polycythemia Vera*/diagnosis
Humans ; Male ; Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Management of polycythemia vera: A survey of treatment patterns in Italy.
Autorzy:
Palumbo GA; Dipartimento di Scienze Mediche, Chirurgiche e Tecnologie Avanzate 'G.F. Ingrassia', University of Catania, Catania, Italy.
Breccia M; Hematology, Department of Precision and Translational Medicine, Policlinico Umberto 1, Sapienza University, Rome, Italy.
Baratè C; Department of Clinical and Experimental Medicine, Section of Hematology, University of Pisa, Pisa, Italy.
Bonifacio M; Department of Medicine, Section of Hematology, University of Verona and AOUI Verona, Verona, Italy.
Elli EM; Hematology Division and Bone Marrow Transplant Unit, Ospedale San Gerardo, ASST Monza, Monza, Italy.
Iurlo A; Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Pugliese N; Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Rossi E; Section of Hematology, Department of Radiological and Hematological Sciences, Catholic University, Fondazione Policlinico A. Gemelli IRCCS, Rome, Italy.
Guglielmelli P; Center of Research and Innovation of Myeloproliferative Neoplasms, AOU Careggi, University of Florence, Florence, Italy.
Palandri F; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy.
Pokaż więcej
Źródło:
European journal of haematology [Eur J Haematol] 2023 Feb; Vol. 110 (2), pp. 161-167. Date of Electronic Publication: 2022 Nov 10.
Typ publikacji:
Journal Article
MeSH Terms:
Polycythemia Vera*/diagnosis
Polycythemia Vera*/epidemiology
Polycythemia Vera*/therapy
Janus Kinase Inhibitors*/therapeutic use
Humans ; Hydroxyurea/therapeutic use ; Pyrazoles/therapeutic use ; Janus Kinase 2 ; Italy/epidemiology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Non-driver gene mutation analysis in a large cohort of polycythemia vera and essential thrombocythemia.
Autorzy:
Morishita S; Laboratory for the Development of Therapies Against MPN, Juntendo University Graduate School of Medicine, Tokyo, Japan.; Advanced Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Hashimoto Y; Advanced Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan.; Department of Hematology, Tottori Prefectural Central Hospital, Tottori, Japan.
Furuya C; Department of Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Edahiro Y; Advanced Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan.; Department of Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Ochiai T; Department of Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Shirane S; Department of Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Inano T; Department of Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Yasuda H; Department of Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Ando M; Department of Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Araki M; Laboratory for the Development of Therapies Against MPN, Juntendo University Graduate School of Medicine, Tokyo, Japan.; Advanced Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Komatsu N; Laboratory for the Development of Therapies Against MPN, Juntendo University Graduate School of Medicine, Tokyo, Japan.; Advanced Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan.; Department of Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan.; PharmaEssentia Japan K.K., Tokyo, Japan.
Pokaż więcej
Źródło:
European journal of haematology [Eur J Haematol] 2023 Feb; Vol. 110 (2), pp. 131-136. Date of Electronic Publication: 2022 Oct 17.
Typ publikacji:
Journal Article
MeSH Terms:
Polycythemia Vera*/diagnosis
Polycythemia Vera*/genetics
Thrombocythemia, Essential*/diagnosis
Thrombocythemia, Essential*/genetics
Primary Myelofibrosis*
Humans ; Prognosis ; Mutation ; Janus Kinase 2/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Cytological Diagnosis of Classic Myeloproliferative Neoplasms at the Age of Molecular Biology.
Autorzy:
Combaluzier S; Hematology Laboratory, Timone University Hospital, 13005 Marseille, France.
Quessada J; Hematological Cytogenetics Laboratory, Timone University Hospital, 13005 Marseille, France.; CNRS, INSERM, CIML, Luminy Campus, Aix-Marseille University, 13009 Marseille, France.
Abbou N; Molecular Biology Laboratory, North University Hospital, 13015 Marseille, France.; INSERM, INRAE, C2VN, Luminy Campus, Aix-Marseille University, 13005 Marseille, France.
Arcani R; INSERM, INRAE, C2VN, Luminy Campus, Aix-Marseille University, 13005 Marseille, France.; Department of Internal Medicine, Timone University Hospital, 13005 Marseille, France.
Tichadou A; Hematology and Cellular Therapy Department, Conception University Hospital, 13005 Marseille, France.
Gabert J; Molecular Biology Laboratory, North University Hospital, 13015 Marseille, France.
Costello R; INSERM, INRAE, C2VN, Luminy Campus, Aix-Marseille University, 13005 Marseille, France.; Hematology and Cellular Therapy Department, Conception University Hospital, 13005 Marseille, France.; TAGC, INSERM, UMR1090, Luminy Campus, Aix-Marseille University, 13005 Marseille, France.
Loosveld M; Hematology Laboratory, Timone University Hospital, 13005 Marseille, France.; Hematological Cytogenetics Laboratory, Timone University Hospital, 13005 Marseille, France.; CNRS, INSERM, CIML, Luminy Campus, Aix-Marseille University, 13009 Marseille, France.
Venton G; INSERM, INRAE, C2VN, Luminy Campus, Aix-Marseille University, 13005 Marseille, France.; Hematology and Cellular Therapy Department, Conception University Hospital, 13005 Marseille, France.; TAGC, INSERM, UMR1090, Luminy Campus, Aix-Marseille University, 13005 Marseille, France.
Berda-Haddad Y; Hematology Laboratory, Timone University Hospital, 13005 Marseille, France.
Pokaż więcej
Źródło:
Cells [Cells] 2023 Mar 20; Vol. 12 (6). Date of Electronic Publication: 2023 Mar 20.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Myeloproliferative Disorders*/diagnosis
Myeloproliferative Disorders*/genetics
Polycythemia Vera*/diagnosis
Polycythemia Vera*/genetics
Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/genetics
Humans ; Mutation/genetics ; Molecular Biology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Polycythemia with elevated erythropoietin production in a patient with a urinary stone and unilateral hydronephrosis: a case report.
Autorzy:
Hajika Y; Department of Internal Medicine, Minami Osaka Hospital, 1-18-18 Higashikagaya, Suminoe-Ku, Osaka, 559-0012, Japan. .
Kawaguchi Y; Department of Internal Medicine, Minami Osaka Hospital, 1-18-18 Higashikagaya, Suminoe-Ku, Osaka, 559-0012, Japan.
Hamazaki K; Department of Internal Medicine, Minami Osaka Hospital, 1-18-18 Higashikagaya, Suminoe-Ku, Osaka, 559-0012, Japan.
Kumeda Y; Department of Internal Medicine, Minami Osaka Hospital, 1-18-18 Higashikagaya, Suminoe-Ku, Osaka, 559-0012, Japan.
Pokaż więcej
Źródło:
Journal of medical case reports [J Med Case Rep] 2023 Mar 09; Vol. 17 (1), pp. 87. Date of Electronic Publication: 2023 Mar 09.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Polycythemia*/complications
Erythropoietin*
Hydronephrosis*/etiology
Urolithiasis*
Urinary Calculi*/complications
Urinary Calculi*/therapy
Male ; Humans ; Middle Aged ; Epoetin Alfa
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Evaluation of pulmonary artery stiffness and right ventricle functions in polycythemia vera patients by transthoracic echocardiography.
Autorzy:
Karaca Y; Department of Cardiology, Elazıg Fethi Sekin City Hospital, Elazıg, Turkey.
Hidayet Ş; Department of Cardiology, Inonu University Faculty of Medicine, Malatya, Turkey.
Bayramoğlu A; Department of Cardiology, Inonu University Faculty of Medicine, Malatya, Turkey.
Yıldırım E; Department of Cardiology, Elazıg Fethi Sekin City Hospital, Elazıg, Turkey.
Berber İ; Department of Adult Hematology, Inonu University Faculty of Medicine, Malatya, Turkey.
Güven F; Department of Cardiology, Inonu University Faculty of Medicine, Malatya, Turkey.
Yiğit Y; Department of Cardiology, Inonu University Faculty of Medicine, Malatya, Turkey.
Ulutaş Z; Department of Cardiology, Inonu University Faculty of Medicine, Malatya, Turkey.
Karaca AD; Department of Internal Medicine, Fırat University Faculty of Medicine, Elazığ, Turkey.
Hidayet E; Department of Adult Hematology, Inonu University Faculty of Medicine, Malatya, Turkey.
Pokaż więcej
Źródło:
Echocardiography (Mount Kisco, N.Y.) [Echocardiography] 2023 Mar; Vol. 40 (3), pp. 196-203. Date of Electronic Publication: 2023 Jan 17.
Typ publikacji:
Journal Article
MeSH Terms:
Polycythemia Vera*/complications
Hypertension, Pulmonary*
Ventricular Dysfunction, Right*
Humans ; Heart Ventricles/diagnostic imaging ; Pulmonary Artery/diagnostic imaging ; Echocardiography/methods ; Lung ; Ventricular Function, Right ; Stroke Volume
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Leukocytosis and MPNs: Where do we stand?
Autorzy:
Coltoff A; Department of Hematology/Oncology, Medical University of South Carolina, Charleston, SC, USA.
Pokaż więcej
Źródło:
Leukemia & lymphoma [Leuk Lymphoma] 2023 Mar; Vol. 64 (3), pp. 564-572. Date of Electronic Publication: 2022 Dec 15.
Typ publikacji:
Journal Article
MeSH Terms:
Myeloproliferative Disorders*/diagnosis
Myeloproliferative Disorders*/epidemiology
Myeloproliferative Disorders*/genetics
Polycythemia Vera*/diagnosis
Polycythemia Vera*/genetics
Thrombocythemia, Essential*/diagnosis
Primary Myelofibrosis*/diagnosis
Thrombosis*
Leukemia, Myeloid, Acute*
Humans ; Leukocytosis ; Retrospective Studies ; Prospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A novel integrated biomarker index for the assessment of hematological responses in MPNs during treatment with hydroxyurea and interferon-alpha2.
Autorzy:
Dam MJB; Centre for Mathematical Modeling - Human Health and Disease (COMMAND), IMFUFA, Department of Science and Environment, Roskilde University, Roskilde, Denmark.
Pedersen RK; Centre for Mathematical Modeling - Human Health and Disease (COMMAND), IMFUFA, Department of Science and Environment, Roskilde University, Roskilde, Denmark.
Knudsen TA; Department of Haematology, Zealand University Hospital, Roskilde, Denmark.
Andersen M; Centre for Mathematical Modeling - Human Health and Disease (COMMAND), IMFUFA, Department of Science and Environment, Roskilde University, Roskilde, Denmark.
Ellervik C; Department of Research, Production, Innovation, Region Zealand, Sorø, Denmark.; Department of Pathology, Harvard Medical School, Boston, Massachusetts, USA.
Larsen MK; Department of Haematology, Zealand University Hospital, Roskilde, Denmark.
Kjaer L; Department of Haematology, Zealand University Hospital, Roskilde, Denmark.
Skov V; Department of Haematology, Zealand University Hospital, Roskilde, Denmark.
Hasselbalch HC; Department of Haematology, Zealand University Hospital, Roskilde, Denmark.
Ottesen JT; Centre for Mathematical Modeling - Human Health and Disease (COMMAND), IMFUFA, Department of Science and Environment, Roskilde University, Roskilde, Denmark.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2023 Feb; Vol. 12 (4), pp. 4218-4226. Date of Electronic Publication: 2022 Oct 17.
Typ publikacji:
Journal Article
MeSH Terms:
Polycythemia Vera*/drug therapy
Myeloproliferative Disorders*/diagnosis
Myeloproliferative Disorders*/drug therapy
Humans ; Hydroxyurea/adverse effects ; Interferon-alpha/adverse effects ; Biomarkers
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Prevalence of elevated hemoglobin and hematocrit levels in patients with obstructive sleep apnea and the impact of treatment with continuous positive airway pressure: a meta-analysis.
Autorzy:
Martelli V; Department of Medicine, University of Toronto, Toronto, Canada.
Carelli E; Department of Medicine, University of Toronto, Toronto, Canada.
Tomlinson GA; Toronto General Hospital Research Institute, Toronto, Canada.; Institute for Health Policy, Management, and Evaluation, University of Toronto, Toronto, Canada.
Orchanian-Cheff A; Library and Information Services, University Health Network, Toronto, Canada.
Kuo KHM; Department of Medicine, University of Toronto, Toronto, Canada.; Division of Medical Oncology & Hematology, University Health Network, Toronto, Canada.
Lyons OD; Department of Medicine, University of Toronto, Toronto, Canada.; Division of Respirology, Women's College Hospital, Toronto, Canada.; Sleep Research Laboratory, Toronto Rehabilitation Institute, Toronto, Canada.; Division of Respirology, University Health Network, Toronto, Canada.
Ryan CM; Toronto General Hospital Research Institute, Toronto, Canada.; Sleep Research Laboratory, Toronto Rehabilitation Institute, Toronto, Canada.; Division of Respirology, University Health Network, Toronto, Canada.
Pokaż więcej
Źródło:
Hematology (Amsterdam, Netherlands) [Hematology] 2022 Dec; Vol. 27 (1), pp. 889-901.
Typ publikacji:
Journal Article; Meta-Analysis
MeSH Terms:
Polycythemia*/epidemiology
Polycythemia*/etiology
Polycythemia*/therapy
Sleep Apnea, Obstructive*/epidemiology
Sleep Apnea, Obstructive*/etiology
Sleep Apnea, Obstructive*/therapy
Adult ; Continuous Positive Airway Pressure/adverse effects ; Hematocrit ; Humans ; Prevalence
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Clinical features of acquired erythrocytosis: Low levels of serum erythropoietin in a subset of non-neoplastic erythrocytosis patients.
Autorzy:
Mori Y; Department of Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Araki M; Laboratory for the Development of Therapies Against MPN, Juntendo University Graduate School of Medicine, Tokyo, Japan.; Department of Advanced Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Morishita S; Laboratory for the Development of Therapies Against MPN, Juntendo University Graduate School of Medicine, Tokyo, Japan.; Department of Advanced Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Imai M; Laboratory for the Development of Therapies Against MPN, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Edahiro Y; Department of Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan.; Laboratory for the Development of Therapies Against MPN, Juntendo University Graduate School of Medicine, Tokyo, Japan.; Department of Advanced Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Ito M; Department of Pathology, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, Nagoya, Japan.
Ochiai T; Department of Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan.; Laboratory for the Development of Therapies Against MPN, Juntendo University Graduate School of Medicine, Tokyo, Japan.; Department of Advanced Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Shirane S; Department of Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan.; Laboratory for the Development of Therapies Against MPN, Juntendo University Graduate School of Medicine, Tokyo, Japan.; Department of Advanced Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Hashimoto Y; Department of Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan.; Laboratory for the Development of Therapies Against MPN, Juntendo University Graduate School of Medicine, Tokyo, Japan.; Department of Advanced Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Yasuda H; Department of Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Ando J; Department of Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan.; Department of Cell Therapy and Transfusion Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Ando M; Department of Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Komatsu N; Department of Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan.; Laboratory for the Development of Therapies Against MPN, Juntendo University Graduate School of Medicine, Tokyo, Japan.; Department of Advanced Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan.; PharmaEssentia Japan KK, Tokyo, Japan.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2023 Jan; Vol. 12 (2), pp. 1079-1089. Date of Electronic Publication: 2022 Jul 01.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Polycythemia*/diagnosis
Polycythemia*/genetics
Polycythemia Vera*/diagnosis
Polycythemia Vera*/genetics
Erythropoietin*
Humans ; Mutation ; Biomarkers
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 21-40 z 11857

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies